Sanofi's $925 Million Toronto Flu Vaccine Plant Brings 300 Skilled Jobs, From Refrigeration Operators to Quality Specialists

Sanofi inaugurated the Charles Best Building in Toronto on September 16, a $925 million flu vaccine plant that the company says is creating approximately 300 highly skilled jobs in advanced biomanufacturing. The building is finished, but the vaccine line is not running yet, and the job count is a promise spread across a project that began in 2021 rather than a stack of open postings you can apply to today. At Metaintro we check the ribbon cutting against the employer's own careers pages and the government funding files, because that is where the real hiring picture sits. Here is what the plant actually is, who it needs, what one of its roles pays, and the training routes that lead to the door.

What Exactly Opened in North York This Week?

A finished building, not yet a working vaccine line. The facility is fully operational and, pending regulatory approval, will begin production in early 2027 in preparation for the 2027-28 flu season. Doses are expected to be ready to begin shipping around next August, ahead of that season.

The product is specific. The plant will make Fluzone High-Dose, a flu shot for adults 65 years of age and older that contains four times the antigen of a standard dose. That narrow focus matters for job seekers, because it tells you which skills the site will lean on hardest, from antigen production through to filled syringes.

The scale is also real. The building covers 263,000 square feet at the Connaught Campus and is the largest manufacturing mandate of its kind for Sanofi's Canadian operations. It sits on the company's 52-acre property near Dufferin and Steeles, a campus that already ships vaccines to more than 60 countries.

This is an old announcement reaching its finish line rather than a fresh one. The plant was first announced in 2021, and the original federal plan expected it to be up and running in 2027. The timetable has held, which is a good sign for anyone weighing whether the jobs are durable.

Are the 300 Jobs New Openings or Already Filled?

This is the question the launch coverage skipped, and the honest answer is that nobody has published a split. Sanofi's own release uses the present tense, saying the expansion is creating approximately 300 highly skilled jobs. Ontario's release describes the building as creating 300 new, good-paying jobs. Neither page says how many of those people are already on the payroll.

The careers site is the better guide. When we searched Sanofi's own listings for Toronto this week, the page returned 17 jobs in Toronto, and only three of them sat under the Manufacturing and Supply function. Most of the rest were data, digital and commercial roles. Sanofi has not said how many of the 300 roles are already filled, so the live listings are the only public measure of what is still open.

So read the headline figure as the size of the permanent workforce the building supports, not as a count of vacancies waiting for applications. The openings that do appear are the ones worth moving on quickly, because they fill the gaps left once the core team is in place.

Why Does the Job Figure Change Depending on Who You Ask?

Because three different numbers describe three different things. Under the 2021 federal contribution, Sanofi committed to create and maintain 1,225 highly skilled jobs in Canada, a commitment that counts existing jobs Sanofi keeps as well as new ones. The Toronto share of that deal was put at some 300 high-quality jobs when it was first unveiled.

Ontario adds up a third figure. Counting this plant, a biomanufacturing facility from 2024 and the expanded AI Centre of Excellence, the province puts Sanofi's investment in Ontario at more than $2 billion with more than 550 new high-value jobs across the three projects.

The practical lesson is to never add these numbers together. The Toronto figure sits inside the national commitment, and it overlaps with the provincial tally. When you see a large jobs figure attached to a factory opening, ask whether it means new hires, retained staff or a multi-year total.

Who Paid for the Plant, and Why Does That Matter to Workers?

Public money is a big part of this building. The $925 million project includes $415 million from the Government of Canada and $55 million from Ontario. The federal share is recorded in the government's own grants database as a $415,000,000.00 contribution through the Strategic Innovation Fund.

That funding record is the most useful page in this story for anyone deciding whether to build a career here. It describes a new bulk vaccine plant plus state of the art formulation, filling, inspection and packaging capabilities in an existing building, with a work phase scheduled to end on March 31, 2027. The agreement itself runs to June 30, 2039, a date that includes a benefit phase and an audit period.

In plain terms, the government is watching the outcomes of this deal for more than a decade. Job commitments tied to public funding are rarely a one year story, which makes the site a steadier bet than a plant built on private money alone. The same file says the goal includes support for large scale manufacturing for global markets, not just Canadian supply.

"This facility will create 300 new, highly skilled, good-paying jobs for our workers," Premier Doug Ford told the inauguration crowd.

What Work Will Actually Happen Inside the Building?

End-to-end vaccine making, which is rarer than it sounds. Sanofi's head of manufacturing and supply for Canada explained that the entire end-to-end production will happen on the campus, from producing the influenza antigens to filling the syringes.

The building will serve as the central hub for the manufacturing, formulation, filling and packaging of the Fluzone High-Dose vaccine. Each of those stages maps to a different kind of worker.

• Bulk manufacturing needs bioprocess operators and technicians who can run upstream and downstream steps under Good Manufacturing Practice rules.
• Formulation needs people who can blend and verify the finished product against a batch record.
• Filling and packaging needs aseptic operators, visual inspectors and packaging line technicians.
• Quality runs through every stage, with quality assurance specialists signing off on deviations and batch records.
• Facilities and utilities keep the clean rooms, cold rooms and steam systems inside tight limits, which is where licensed trades come in.

The last group is easy to miss. A vaccine plant runs on refrigeration, air handling and clean utilities, and those jobs go to certified tradespeople rather than lab scientists.

What Does a Sanofi Toronto Plant Job Pay and Require?

One live posting answers both questions in writing. Sanofi's opening for a Refrigeration Facilities Operator in Toronto is a full time, permanent job with a posted pay rate of $54.52 an hour. The shift is set out too, running Monday to Friday from 7:00am to 3:00pm.

The bar to entry is clear. The posting asks for a high school diploma, a minimum four year accredited certificate program such as a valid Ontario Refrigeration Certificate, and at least four years of relevant work experience. Experience troubleshooting equipment in a GMP facility is listed as a plus, along with building automation, HVAC and blueprint reading. It also warns that an application without an attached resume will not be considered.

The quality side looks different. A current Quality Assurance Specialist opening sits in the Quality Assurance, FFIP department on a one year fixed term contract, and its scope can include the formulation, filling and packaging area at the Toronto site. It requires a Bachelor of Science with 3 or more years of experience in a pharmaceutical or biological manufacturing environment, plus strong knowledge of current Good Manufacturing Practices and root cause investigation. The posting states that it is a new vacant role, not a replacement.

That QA posting does not list a pay figure, so ask for the range early in the process. Our guide to salary transparency in Ontario's job market covers why posted pay has become a bigger issue in the province and how to raise it without hurting your chances.

How Can Students Get a Foot in the Door?

Through co-op, which the funding deal built in from the start. The 2021 federal agreement said the project would create another 200 co-op positions on top of the permanent jobs.

The current intake is open. Sanofi's January 2027 Co-Op University Recruitment Program places students at the Toronto Campus on Steeles Avenue West or at the AI Centre of Excellence downtown. The listed areas include bulk manufacturing, filling and packaging, bioprocess R&D, site quality operations, manufacturing technology and supply chain management, which are exactly the teams a new vaccine plant leans on.

The rules are strict, so read them before you apply. Students must have completed at least one year of university, stay enrolled for the whole placement, work 37.5 hours per week Monday to Friday, and hold a minimum GPA of 3.0 on a 4.0 scale. Sanofi also asks applicants to confirm eligibility with their own university co-op office first, and says general applications will not be considered.

A co-op term inside a GMP plant is the single most valuable line a biomanufacturing graduate can put on a resume, because it proves you have worked under batch record discipline. If you are still weighing the field, our look at what a biotech career pays sets out the salary ladder you would be climbing.

What If You Trained Abroad in Life Sciences?

Ontario has a funded bridge built for exactly this situation. ACCES Employment runs Connecting to Careers in Biomanufacturing, a full time, hybrid 7-week program for internationally trained newcomers with life sciences backgrounds, followed by 12 months of job coaching.

The training is industry facing rather than academic. It is delivered with the Canadian Advanced Therapies Training Institute, BioTalent Canada and Toronto Metropolitan University, and covers GMP onboarding, technical fundamentals and biomanufacturing communication, with employer panels, speed mentoring and job fairs built in.

Eligibility is specific. Applicants need to be a newcomer to Canada, hold Canadian Language Benchmark Level 7, and have at least two years of professional biomanufacturing experience outside Canada. The next tentative cohort runs from October 12 to November 27, 2026, the fee is $350 plus HST, and eligible participants can apply to the Ontario Bridging Participant Assistance Program for help with the cost.

For people already working in Canada who want to move sideways into the field, the University of Toronto School of Continuing Studies offers biomanufacturing micro-credentials with the Faculty of Applied Science and Engineering, and eligible learners can apply to OSAP. Check the course list first, because the school says its GMP and quality assurance modules are temporarily on hold.

"It helps to prevent 15,000 hospitalizations every year," the plant's manufacturing head said of the vaccine.

Why Is Canada Paying to Make Its Own Flu Shots?

Because the pandemic exposed how exposed the country was. Federal Industry Minister Mélanie Joly tied the plant to the vulnerabilities in access to vaccines and medical supplies that leaders discovered during the COVID pandemic.

The original federal release set the pandemic goal in concrete terms. In a future flu outbreak, the Toronto site should be able to produce enough doses to support the entire Canadian population within approximately six months of the World Health Organization identifying a pandemic strain.

Trade pressure has added a second reason. The launch came in the same week the federal government hosted its first Canada Investment Summit, while Washington has been pressing drug makers to move their manufacturing to the United States, which Joly called the weaponization of trade. For workers, that political backing is a form of job security, since a plant built as national infrastructure is harder to close quietly.

How Big Is Sanofi's Toronto Workforce Already?

Big enough that this plant joins an established employer rather than starting from scratch. Sanofi says it has 2,000+ employees in Canada and is on track to deliver over $2 billion in new infrastructure investments by 2028.

The company's own careers page calls the Toronto Campus the largest biomanufacturing site in Canada with its most technologically advanced production capabilities. That history runs deep, since the campus traces back to a small lab at the University of Toronto, a lineage Toronto Mayor Olivia Chow recalled at the opening ceremony.

The building is named after Charles Best, who with Frederick Banting isolated insulin at the University of Toronto in 1921. For job seekers the relevant point is less the history than the size. A large, established site has internal job boards, shift rotations and promotion paths that a new startup plant cannot match.

What This Means for Job Seekers, and What Should You Do Next?

Treat this as a slow build, not a hiring rush. The building is done, and the next real wave of demand comes as production starts in early 2027 and the line moves toward commercial volume. The people who get hired in that wave will be the ones who are already known to the site.

Pick your lane first. If you hold a trade ticket, the facilities side is where the posted pay is highest and the competition from lab graduates is lowest. If you have a science degree and some manufacturing time, quality assurance in filling and packaging is the clearest entry. If you are still studying, the co-op program is the most direct route, and it is the one the funding deal was built to support.

Get the GMP vocabulary right before you apply. Deviations, CAPAs, batch records and root cause analysis appear in almost every Sanofi manufacturing posting, and a resume that uses those terms correctly reads as someone who has done the work. A lab technician certification is a cheap way to show you understand controlled lab practice if you are coming from outside the industry.

Set a job alert on the careers site rather than checking once. With only a handful of plant roles live at a time, the advantage goes to whoever applies in the first days. And be sceptical of any recruiter who promises you one of the 300 jobs for a fee, because Sanofi's careers site warns that the company never charges candidates any fees.

Related Articles

• Pharmacist Salary and How to Earn More
• Skills for Your Manufacturing Resume
• How to Get Machinist Certification and Advance Your Manufacturing Career
• How a New FDA Program Could Bring Drug Manufacturing Jobs Back to the US
• Canada Bets Big on AI to Counter US Pressure, the Jobs Strategy Behind It
• Canada's Job Market Reality Check
• US Manufacturing Has a Worker Problem, Key Warnings From McKinsey's New Report
• Why AI Won't Save Manufacturing Jobs Until Companies Fix the Work First
• Pharmacist Cover Letter Guide

People Also Asked

Q: How many jobs will the Sanofi Toronto vaccine plant create?

A: Sanofi says the expansion is creating approximately 300 highly skilled jobs in advanced biomanufacturing, but it has not said how many are already filled, and its Toronto careers page listed only a small number of plant roles when we checked.

Q: When will the Charles Best Building start making vaccines?

A: The building is fully operational and, pending regulatory approval, will begin production in early 2027 for the 2027-28 flu season.

Q: How can a newcomer get into biomanufacturing in Ontario?

A: The Connecting to Careers in Biomanufacturing program from ACCES Employment offers a 7-week hybrid course plus 12 months of job coaching for newcomers with at least two years of biomanufacturing experience abroad.

Ready to explore? Metaintro tracks hiring across the whole market, so you can spot new plant and lab roles the week they go live. Create a free profile and be first in line when the next biomanufacturing opening lands.